Researchers have used DNA sequencing to find a specific gene, which, when mutated, serves as a biochemical pathway for the growth of a certain form of lung cancer. Having found this specific mutated gene, the researchers are working to create a drug that will block the gene's activity. By blocking the gene's activity, the researchers believe, they can stop the growth of that form of cancer.
The answer to which of the following questions would be most valuable in assessing the likelihood of the plan working?
(A) Can a person experience more than one type of cancer simultaneously?
(B) Would using a targeted approach that blocks genes in cancer cells have fewer side effects than do currently used treatment modalities?
(C) What is a typical cost of taking such a drug from development to mass manufacture?
(D) Can cancer cells shift from using one biochemical growth pathway to using another?
(E) For what percentage of forms of cancer is DNA sequencing effective in finding genes that serve as pathways for growth of the forms?
Argument says that gene, if mutated, can create biochemical pathway for the growth of lung cancer. then it goes on saying that researchers are working to create a drug that will block the gene's activity and it, in turns, helps stop the growth of that form of cancer.
what happened if scientist can't find the specific mutated gene. if this happens, whole exercise becomes futile and argument shall be weakened.
with this in mind, now come to the options.
Option D identifies a scenario under which cancer cells shift from using one biochemical growth pathway to other. it means they are using several biochemical pathways. so, it is difficult to identify a single mutated gene and hence, all becomes useless.
So, option D is the answer.